Camas, Katherine P.

HRN: 22-97-22  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/29/2023
CEFUROXIME 1.5GM (VIAL)
05/29/2023
05/31/2023
IVTT
1.5g
Q8 X 3 Doses
Sp Tabhso
Checking Final Appropriateness 

Indication:  Empiric    Type of Infection:  Reproductive Tract    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Intervention



Type of Intervention done:

                    

           


Acceptance: